posted on 2017-01-26, 00:00authored byXiang Ren, Parham Ghassemi, Hesam Babahosseini, Jeannine S. Strobl, Masoud Agah
A microfluidic
device composed of variable numbers of multiconstriction
channels is reported in this paper to differentiate a human breast
cancer cell line, MDA-MB-231, and a nontumorigenic human breast cell
line, MCF-10A. Differences between their mechanical properties were
assessed by comparing the effect of single or multiple relaxations
on their velocity profiles which is a novel measure of their deformation
ability. Videos of the cells were recorded via a microscope using
a smartphone, and imported to a tracking software to gain the position
information on the cells. Our results indicated that a multiconstriction
channel design with five deformation (50 μm in length, 10 μm
in width, and 8 μm in height) separated by four relaxation (50
μm in length, 40 μm in width, and 30 μm in height)
regions was superior to a single deformation design in differentiating
MDA-MB-231 and MCF-10A cells. Velocity profile criteria can achieve
a differentiation accuracy around 95% for both MDA-MB-231 and MCF-10A
cells.